Galedra
Sign in Sign up

Claims

As of snapshot 27745 under ledger-default@0.3.0.

ClaimTypeAssessmentScoreReview checksReferences
In a randomized noninferiority evaluation of 355 retrospectively collected oncology charts from patients with non-small-cell lung or colorectal cancer, mean chart-review time as a secondary efficiency endpoint was similar for Human+AI and Human-alone prescreening (37.4 versus 37.8 minutes). QUANTITATIVE Supported 0.8581 1 of 4 95